» Articles » PMID: 7794570

Magnetic Resonance Imaging Compared to Echocardiography to Assess Left Ventricular Mass in the Hypertensive Patient

Overview
Journal Am J Hypertens
Date 1995 Mar 1
PMID 7794570
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Echocardiography (ECHO) is useful to document changes in left ventricular mass (LVM) in groups of patients, but may be too variable for use in the individual patient. Magnetic resonance imaging (MRI) may be a more precise and reliable method to quantify the mass of the left ventricule. This study reports the accuracy, precision, and reliability of LVM estimates by MRI as compared to data obtained by ECHO in hypertensive patients. Accuracy referred to the comparison of LVM by MRI to anatomical LVM determined by autopsy. Precision was examined using 34 duplicate MRI images and by blindly reading 24 duplicate M-mode strips. Reliability was assessed by MRI in four subjects over 2 months, and by ECHO in 22 hypertensive patients over 2 weeks. Agreement between MRI and ECHO estimates of LVM was determined in the same 17 hypertensive patients using linear regression. MRI LVM estimates were within 17.5 g (95% CI) of the true LVM. The linear agreement between MRI and ECHO estimates of LVM could be described by the equation MRI = 0.61 x ECHO + 49.57 (r = 0.63, P < .01). The precision of LVM by MRI (11 g) was over twice that observed with ECHO (26 g). The reliability of MRI LVM estimates was more consistent (+/- 8 g) than that for ECHO (+/- 49 g). MRI appears to be a more precise and reliable method for measuring LVM, and would be more suitable than ECHO for the clinical evaluation of the individual patient.

Citing Articles

The impact of exercise intensity and duration for swim training-induced adaptations in cardiac structure and function in women with mild hypertension.

Sjurdarson T, Nordsborg N, Kristiansen J, Andersen L, Krustrup P, Kyhl K Physiol Rep. 2024; 12(21):e70116.

PMID: 39487596 PMC: 11530408. DOI: 10.14814/phy2.70116.


The Depiction of Hypertension in Heart Imaging Examinations: An Up-to-Date Review of the Evidence.

Vasileiadis K, Antza C, Kotsis V Vasc Health Risk Manag. 2023; 19:789-796.

PMID: 38045022 PMC: 10693270. DOI: 10.2147/VHRM.S436133.


Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease.

Gatterer C, Beitzke D, Graf S, Lenz M, Sunder-Plassmann G, Mann C Life (Basel). 2023; 13(5).

PMID: 37240859 PMC: 10222787. DOI: 10.3390/life13051213.


The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.

Pan K, Hsu Y, Chang S, Chung C, Lin C Int J Mol Sci. 2023; 24(10).

PMID: 37239956 PMC: 10218088. DOI: 10.3390/ijms24108604.


Utilization and impact of cardiovascular magnetic resonance on patient management in heart failure: insights from the SCMR Registry.

Roifman I, Hammer M, Sparkes J, DallArmellina E, Kwong R, Wright G J Cardiovasc Magn Reson. 2022; 24(1):65.

PMID: 36404335 PMC: 9677679. DOI: 10.1186/s12968-022-00890-0.